AI Powered Digital Biomarkers
are Driving Change in Clinical Trials
AI Powered Digital Biomarkers are
Driving Change in Clinical Trials
Utilization of Imaging Biomarkers in Clinical Trials Has Grown 700%
Utilization of Imaging Biomarkers in Clinical Trials Has Grown 700%
VIDA Intelligence Platform TM
We enable sponsors to collect and leverage high quality imaging data throughout the drug development and clinical trial process.Our services are enabled by the VIDA Intelligence Platform.
We enable sponsors to collect and leverage high quality imaging data throughout the drug development and clinical trial process.
Our services are enabled by the VIDA Intelligence Platform.
Clinical Trial Imaging
VIDA’s platform-enabled services enable exceptional imaging data quality & highly efficient site operations.
AI-Powered Digital Biomarkers
Image analysis includes radiology assessments (e.g., eligibility reads, safety reads, adjudication) and AI-powered algorithms to produce quantitative imaging biomarkers.
Site Management
Site management includes digital site onboarding activities (e.g., site training, scanner certification) and ongoing proactive site support throughout the trial.
Sponsor Trial Orchestration
VIDA’s platform offers sponsors access to trial imaging data, key performance metrics, site activity, and more.
Research and Commercial Planning
Clinical and operational data informs biomarker & site selection, in addition to novel services like external control arms & digital twins.
Trial Workflow Design
VIDA assists with trial workflow strategies (e.g. considerations for safety reads, adjudication, etc.).
Site Matching
Sponsors can leverage operational data to select high-performing sites that meet trial criteria. VIDA’s network of freestanding imaging facilities can be paired with trial centers who lack imaging capabilities, and/or to expand geographic access to trial imaging.
External Control Arms
Reduce trial size by creating a control arm from the digital biobank.
Therapeutic Research
Researchers and sponsors leverage rich data repositories to examine cohorts, better understand disease, & discover new biomarkers.
Disease Phenotyping
Discover patterns in the data to inform more targeted therapies.
Biomarker Discovery
Identify new digital biomarkers behind responder cohorts.
Retrospective Analysis
Leverage the ongoing value of high quality imaging datasets by applying new biomarkers to the data.
Therapeutic Areas
Therapeutic Areas
Any trial with imaging can benefit from our platform-based
trial imaging services & expert reading services.
Our AI-powered imaging biomarkers span all major respiratory
diseases, and now include digital biomarkers for cardiovascular
and oncology trials. With best-in-breed partnerships, we are quickly
integrating AI-powered analysis across new modalities & therapeutics.
Any trial with imaging can benefit from our platform-based trial imaging services & expert reading services.
Our AI-powered imaging biomarkers span all major respiratory diseases, and now include digital biomarkers for cardiovascular and oncology trials. With best-in-breed partnerships, we are quickly integrating AI-powered analysis across new modalities & therapeutics.
Respiratory
VIDA’s foundation is quantitative imaging for all major respiratory diseases, including COPD, asthma, ILD/IPF, cystic fibrosis, COVID-19, and more.
We produce up to 15,000 individual metrics from a single imaging scan, spanning 50+ biomarkers to measure airway, tissue, and vascular remodel, along with lung function (e.g., ventilation, air trapping).
Cardiovascular
Several major cardiovascular conditions, noted below, are serviced by VIDA’s range of vascular and cardiac biomarkers. VIDA’s cardiovascular biomarkers include CT and MRI-based data, from gated/non-gated, or contrast/non-contrast acquisitions.
Oncology
VIDA’s oncology biomarker offering includes standard tumor response measures like RECIST 1.1, in addition to more advanced tumor analysis.
VIDA’s oncology capabilities spans solid tumors in the chest or body, imaged with CT, MRI or PET/CT scanners.
Neurology
VIDA’s team of expert radiology reviewers provides quantitative analysis for neurology trials.
Musculoskeletal
VIDA’s team of expert radiology reviewers provides quantitative analysis for MSK trials.
Gastroenterology
VIDA’s team of expert radiology reviewers provides quantitative analysis for gastroenterology trials.
What is a Digital Biobank?
A digital biobank is analogous to a traditional tissue/blood biobank, but for digital patient information over time, including imaging data, test results, demographics, diagnoses, and much more.
The Power of a Digital Biobank
Life-sciences companies are leveraging digital biobanks and AI to modernize drug development and clinical trials.
Strategic Partners
Experience the future of lung function
analysis with Polarean’s innovative Xenon
MRI solution, now integrated into the VIDA
Intelligence Platform for trial sponsors. More info
Thirona provides advanced AI-powered analysis of thoracic imaging, built on robust segmentation and precise quantification of bronchial, parenchymal, and vascular lung structures. Thirona’s analyses are available through VIDA’s trial imaging solutions. More info
Riverain’s ClearRead CT technology deploys a series of advanced AI algorithms to provide key insights and metrics on pulmonary nodules, coronary artery calcification (CAC), and hypodense lung tissue*. The quantification of these biomarkers is available through VIDA’s trial imaging solution. More info
VIDA has added DTA Fibrosis Score to its ILD imaging solution for clinical trials. DTA is a well-validated, deep learning-based solution that automatically quantifies lung fibrosis on high-resolution computed tomography (HRCT) scans. More info
VIDA’s cloud platform powers OSIC Cloud,
the world’s largest and most diverse global
repository for interstitial lung diseases.
VIDA leverages the latest aws technologies
for the VIDA Intelligence Platform.
Our Leadership Team
Our
Leadership Team
Susan Wood, PhD | Chief Executive Officer
Dr. Wood has 30+ years of experience championing innovative clinical solutions to the marketplace, from concept to revenue. Dr. Wood previously held leaderships positions at R2 (Hologic), Vital Images (Canon), and iCAD (RadNet). She received her Ph.D. from the Johns Hopkins Medical Institutions, School of Hygiene and Public Health. Dr. Wood also holds a Master of Science degree in Biomedical Engineering from Duke University, and a Bachelor of Science in Engineering from the University of Maryland, College Park.
Sandra Stapleton | Chief Operating Officer
Ms. Stapleton has over 25 years’ experience in building and managing operational and engineering functions, as well as developing leading-edge products in the healthcare field. Previously, she held leaderships positions at R2 (Hologic), Claron (Lexmark), and Cedara (Merative). Ms. Stapleton received her MSc. in Medical Biophysics, along with a BSc. degree, from the University of Toronto.
Todd Johnson | Chief Technology Officer
Mr. Johnson has over 25 years of experience in the clinical imaging and healthcare IT industries. He led product and technology teams at Change Healthcare (Optum Health) and Vital Images (Canon). Mr. Johnson received degrees in Biomedical & Electrical Engineering from the University of Iowa, and earned his MBA from the University of Minnesota.
Lars Nordenmark, PhD | Chief Scientific Officer
Mr. Nordenmark has over 30 years experience in medical imaging, biomarkers, and clinical research. He previously spent 16 years at AstraZeneca, where he advanced global R&D strategy in translational imaging and biomarker science. He is widely published on CT densitometry and image-based clinical trial endpoints and holds patents in advanced image analysis. Mr. Nordenmark earned a PhD in Biomedical Engineering from Linköping University and conducted a postdoctoral fellowship at Stanford University.
Data Security and Compliance
Data Security and Compliance
VIDA’s data security and privacy practices are HIPAA compliant. Our quality system is certified to the ISO 13485:2016 standard, complies with FDA Part 11 requirements, and reflects security and privacy measures that align with industry standard best practices. Data is secured with AES256-bit encryption.
